New and Upcoming Activities

This four-session online case-based learning collaborative series is designed for healthcare professionals treating individuals with opioid use disorder (OUD). Each 1.5-hour live, virtual session will feature an educational presentation on OUD and real-world case discussions led by addiction experts, providing practical insights and actionable strategies to improve patient care. Participants will explore best practices, discuss challenges, and collaborate on solutions in an engaging, interactive format.

Many cities, and especially cities with high real estate prices, have clearly defined zones in which public drug use and sales are implicitly tolerated while more stringent enforcement continues everywhere else. Given that addiction services (like methadone clinics or residential programs) are often mobilized to serve these zones and/or deliberately segregated to remain within them--what should our relationship to these zones be as addiction care providers? The podcast will explore the challenges, problems, and opportunities these zones can create for people who use drugs and the providers who care for them.

This training is available virtually. To register, please email: [email protected].

Consider approaches to sustain MOUD and ensure continued access to high-quality care for our most challenged patients, including those who are pregnant, youth/adolescents, those with acute or chronic pain, and those electing to taper their dose.

Review considerations for MOUD initiation and follow-up, including lab guidelines, and clinical management of patients with continued use (e.g., fentanyl, novel synthetic opioids), overdose risk, poly-substance use, and comorbid mental health conditions.

Review patient screening considerations and discuss how OUD screening can be integrated into current clinic workflows. Discuss the training and certifications required for specific team members to implement MOUD. Highlight the critical role of Champions, and how to strategically select Champions to support MOUD implementation.

Review medications for opioid use disorders (MOUD), with a focus on buprenorphine treatment and its various formulations, and strategies for including harm reduction approaches into care. Discuss administrative, clinical and financial considerations, and provide resources for both prescribers and non-prescribers.

Join this PCSS-MOUD Clinical Roundtable which offers a chance to learn from and engage with our clinical experts! Lead Mentor Debra Newman, PA-C, MSPAS, MPH will The hour is comprised of a slide presentation and an open question session. Attendees will be given the opportunity to speak directly with the presenter to ask questions and discuss issues.

This educational activity, presented by Dr. Phillip Coffin, explores the evolving landscape of methamphetamine use amidst the growing presence of fentanyl. Attendees will gain insights into current morbidity and mortality trends, the physiological mechanisms behind methamphetamine toxicity, and evidence-based interventions for managing methamphetamine use disorder (MeUD). Emphasis will be placed on comprehensive prevention, treatment strategies, and addressing the long-term cardiovascular and neuropsychiatric impacts associated with chronic use.

Sound ethics and boundaries are critical to the provision of Substance Use Disorder treatment. Ethical behaviors and boundaries support a client's treatment process, foster a positive client recovery environment, and promote service engagement. On the other hand, challenges related to unethical practices and boundaries can impact the professionals' well-being, resulting in negative job consequences. In this training, participants will reflect on their experiences with ethical dilemmas and explore strategies to deliver effective and professional care to SUD clients.